A Study to Evaluate the Safety and Pharmacokinetics of CDX-0158 in Adult Patients With Advanced Solid Tumors
Clinical trial NCT02642016 · COMPLETED
Trial details
- NCT number
- NCT02642016
- Sponsor
- Celldex Therapeutics
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2018-01-30
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.